Exploring Models for an International Legal Agreement on the Global Antimicrobial Commons: Lessons from Climate Agreements.

IF 1.8 3区哲学 Q2 ETHICS Health Care Analysis Pub Date : 2023-03-01 DOI:10.1007/s10728-019-00389-3

Susan Rogers Van Katwyk, Alberto Giubilini, Claas Kirchhelle, Isaac Weldon, Mark Harrison, Angela McLean, Julian Savulescu, Steven J Hoffman

{"title":"Exploring Models for an International Legal Agreement on the Global Antimicrobial Commons: Lessons from Climate Agreements.","authors":"Susan Rogers Van Katwyk, Alberto Giubilini, Claas Kirchhelle, Isaac Weldon, Mark Harrison, Angela McLean, Julian Savulescu, Steven J Hoffman","doi":"10.1007/s10728-019-00389-3","DOIUrl":null,"url":null,"abstract":"<p><p>An international legal agreement governing the global antimicrobial commons would represent the strongest commitment mechanism for achieving collective action on antimicrobial resistance (AMR). Since AMR has important similarities to climate change-both are common pool resource challenges that require massive, long-term political commitments-the first article in this special issue draws lessons from various climate agreements that could be applicable for developing a grand bargain on AMR. We consider the similarities and differences between the Paris Climate Agreement and current governance structures for AMR, and identify the merits and challenges associated with different international forums for developing a long-term international agreement on AMR. To be effective, fair, and feasible, an enduring legal agreement on AMR will require a combination of universal, differentiated, and individualized requirements, nationally determined contributions that are regularly reviewed and ratcheted up in level of ambition, a regular independent scientific stocktake to support evidence informed policymaking, and a concrete global goal to rally support.</p>","PeriodicalId":46740,"journal":{"name":"Health Care Analysis","volume":"31 1","pages":"25-46"},"PeriodicalIF":1.8000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s10728-019-00389-3","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10728-019-00389-3","RegionNum":3,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ETHICS","Score":null,"Total":0}

引用次数: 31

Abstract

An international legal agreement governing the global antimicrobial commons would represent the strongest commitment mechanism for achieving collective action on antimicrobial resistance (AMR). Since AMR has important similarities to climate change-both are common pool resource challenges that require massive, long-term political commitments-the first article in this special issue draws lessons from various climate agreements that could be applicable for developing a grand bargain on AMR. We consider the similarities and differences between the Paris Climate Agreement and current governance structures for AMR, and identify the merits and challenges associated with different international forums for developing a long-term international agreement on AMR. To be effective, fair, and feasible, an enduring legal agreement on AMR will require a combination of universal, differentiated, and individualized requirements, nationally determined contributions that are regularly reviewed and ratcheted up in level of ambition, a regular independent scientific stocktake to support evidence informed policymaking, and a concrete global goal to rally support.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

探索全球抗菌药物共享国际法律协议的模式：气候协议的经验教训。

管理全球抗菌药物共有权的国际法律协议将是实现抗菌药物耐药性集体行动的最强有力的承诺机制。由于AMR与气候变化有着重要的相似之处，两者都是共同的资源库挑战，需要做出大规模、长期的政治承诺，本期特刊的第一篇文章从各种气候协议中吸取了教训，这些协议可能适用于制定AMR的大交易。我们考虑了《巴黎气候协定》与当前AMR治理结构之间的异同，并确定了不同国际论坛在制定AMR长期国际协议方面的优点和挑战。为了有效、公平和可行，一项关于AMR的持久法律协议将需要结合普遍、有区别和个性化的要求，定期审查和提高雄心的国家自主贡献，定期进行独立的科学评估以支持循证决策，以及争取支持的具体全球目标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Health Care Analysis Multiple-

CiteScore

4.20

自引率

0.00%

发文量

期刊介绍： Health Care Analysis is a journal that promotes dialogue and debate about conceptual and normative issues related to health and health care, including health systems, healthcare provision, health law, public policy and health, professional health practice, health services organization and decision-making, and health-related education at all levels of clinical medicine, public health and global health. Health Care Analysis seeks to support the conversation between philosophy and policy, in particular illustrating the importance of conceptual and normative analysis to health policy, practice and research. As such, papers accepted for publication are likely to analyse philosophical questions related to health, health care or health policy that focus on one or more of the following: aims or ends, theories, frameworks, concepts, principles, values or ideology. All styles of theoretical analysis are welcome providing that they illuminate conceptual or normative issues and encourage debate between those interested in health, philosophy and policy. Papers must be rigorous, but should strive for accessibility – with care being taken to ensure that their arguments and implications are plain to a broad academic and international audience. In addition to purely theoretical papers, papers grounded in empirical research or case-studies are very welcome so long as they explore the conceptual or normative implications of such work. Authors are encouraged, where possible, to have regard to the social contexts of the issues they are discussing, and all authors should ensure that they indicate the ‘real world’ implications of their work. Health Care Analysis publishes contributions from philosophers, lawyers, social scientists, healthcare educators, healthcare professionals and administrators, and other health-related academics and policy analysts.